Healthcare and Life Science
Cresset CEO’s end of year message 2022
As we near the end of another year, Dr Robert Scoffin, CEO of Cresset, reflects on the events of 2022 ...
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumours. ...
Metrion Biosciences invests in new High Throughput Screening capability and expanded facilities
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has ...
Gyros Protein Technologies adds Gyrolab® Biomarker Kits to expand range of ready-to-use kits and reagents
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today introduced Gyrolab® Human Cytokine Kit Reagents, the first in a range of new biomarker kits. These include five single analyte biom...
Biocair develops dedicated team for cell and gene therapy logistics
Biocair has invested heavily in the creation of a specialist logistics team to meet the complex needs of the rapidly expanding cell and gene therapy sector. ...
Arecor granted key patent In Japan and South Korea to protect proprietary insulin products At247 and At278
The granted patents further strengthen the Group’s extensive patent portfolio protecting its proprietary Arestat™ technology and diabetes product portfolio ...
Biocair expands its European network with a new Paris operational hub
Experts in logistics for the healthcare industry for more than 35 years, Biocair continues to expand in response to the growing demand from European players in the biotech and healthcare sectors. ...
Pure wins UK Employer of the Year Gold from Investors in People
The Pure Resourcing Solutions team is thrilled to announce that they have been awarded the Investors in People’s (IIP) UK Employer of the Year Gold award (50–249 employees). ...
Arecor to commence second clinical trial with at278 ultra-concentrated ultra-rapid acting insulin candidate for type 2 diabetes
Clinical trial application approved - EU Phase I clinical trial expected to commence in December 2022 ...
Community nurses get a boost from new kit bags
Community nursing teams at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) have won national funding for new branded bags to organise essential kit for care visits and save them extra time and travel. ...